Table 2.
Cytotoxic activity of 2 and 6 against both normal Vero Cells and PBMC isolated from healthy volunteers.a,b
Compound | Test MRSA strains | Vero cells cytotoxicity IC50±SEM (μg/mL) |
PBMC cytotoxicity IC50±SEM (μg/mL) |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Therapeutic Index (TI)c | ||||||||||
| ||||||||||
ATCC 43300 |
CI 1 | CI 2 | CI 3 | CI 4 | CI 5 | CI 6 | CI 7 | |||
2 | 0.4 | 0.3 | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 5.7 ± 0.4 | 46.9 ± 0.8 |
4 | 13.5 | 16.4 | 13.8 | 10.9 | 10.6 | 13.5 | 12.1 | 14.7 | 1.6 ± 0.4 | 68.9 ± 0.7 |
6 | 6.2 | 8.1 | 7.1 | 7.2 | 9.9 | 9.7 | 6.3 | 7.2 | >100.0 | 246.8 ± 12.8 |
Experiments were performed in triplicate (N =3).
CI = Clinical isolate of methicillin-resistant S. aureus.
TI was determined by dividing PBMC cytotoxicity by the inhibitory concentration (IC50) of the drug.